The s/c data will be positive (is positive) but wi

The s/c data will be positive (is positive) but will the FDA find a reason to delay and/or to reject?

Is the FDA actually corruptible? Will BP actually influence the FDA not to give us an EUA?

I don't know, I'm not privy to that level of potential corruption.

Some say yes, the FDA is corruptible and might delay or reject leronlimab due to influence or due to favoritism toward BigPharma companies. Some say, "what, are you naive/stupid? Of course the FDA is corruptible>

However, no BP has anywhere near the quality of, the efficacy and safety of, leronlimab for s/c covid-19 patients, a group from which all covid-19 deaths come.

By rejecting leronlimab's EUA, the FDA would be blatantly turning a switch to continue the deaths of s/c patients.